Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Text message Check-Up could stop surgery pain from lingering

NCT ID NCT07160595

Disease control Sponsor: Fondation Hôpital Saint-Joseph Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether identifying and treating persistent pain just 3 months after surgery can stop it from becoming chronic. Over 2000 patients having common minor surgeries will be screened via SMS and either get early treatment or standard care. The goal is to see if early action reduces the number of people still in pain at 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
early management of postoperative pain via SMS screening and prompt treatment
What this could lead to
If successful, this could show that early detection and treatment of pain after surgery prevents it from becoming chronic, improving recovery for many patients.
What could go wrong
This is a relatively early-stage trial without a drug, so the benefit may be small or not apply to all surgeries. The approach relies on patient response to SMS, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,052 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2025

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have undergone one of the following procedures: * Inguinal hernia repair, regardless of the surgical technique used * Breast reduction * Mastectomy with or without reconstruction but with lymph node dissection * Knee arthroscopy or knee ligamentoplasty * Patients with a smartphone * French-speaking patients * Patients affiliated with a social security * Patients who have given their free and informed verbal consent Exclusion Criteria: * Patients with pain sensitivity defined by the presence of chronic pain, use of level 3 morphine analgesics, use of anxiolytics, gabapentinoids and/or antidepressants * Patients subject to legal protection measures * Patients deprived of their liberty * Pregnant, labouring or breastfeeding patients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic postoperative pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic postoperative pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP-HP : Hôpital Saint-Louis

    Paris, France

  • AP-HP : Hôpital de la Pitié Salpêtrière

    Paris, France

  • CHU de Saint-Etienne

    Saint-Etienne, France

  • CHU de Toulouse

    Toulouse, France

  • Clinique Drouot Remusat

    Paris, France

  • Clinique Geoffroy Saint Hilaire

    Paris, France

  • Clinique Jules Verne

    Nantes, France

  • Hospices Civils de Lyon

    Lyon, France

  • Hôpital Foch

    Suresnes, France

  • Hôpital Paris Saint-Joseph

    Paris, France

  • Hôpital Prive Claude Galien

    Boussy-Saint-Antoine, France

  • Hôpital Privé du confluent Santé Atlantique

    Nantes, France

  • Hôpital de la Croix Saint-Simon

    Paris, France

  • Institut Curie : Hôpital de Paris

    Paris, France

  • Institut Curie : Hôpital de Saint Cloud

    Saint-Cloud, France

  • Institut Mutualiste Montsouris

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.